Clinical trials
Phase 1/2 Blastic Plasmacytoid Dendritic Cell Neoplasm trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 1 |
| Beijing Biotech | 1 |
| Chongqing Precision Biotech Co., Ltd | 1 |
| Fondazione Matilde Tettamanti Menotti De Marchi Onlus | 1 |
| Mustang Bio | 1 |
| Stemline Therapeutics, Inc. | 1 |
| University of Texas Southwestern Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blastic Plasmacytoid Dendritic Cell Neoplasm | 7 |
| Leukemia, Myeloid, Acute | 6 |
| Leukemia | 2 |
| Recurrence | 2 |
| Burkitt Lymphoma | 1 |
| Congenital Abnormalities | 1 |
| Hematologic Neoplasms | 1 |
| Leukemia, Plasma Cell | 1 |
| Lymphoma, B-Cell | 1 |
| Lymphoma, T-Cell, Peripheral | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.